Document is current
Any future updates will be listed below
-
Authors
Jiao, Xuanmao
Wang, Min
Zhang, Zhao
Li, Zhiping
Ni, Dong
Ashton, Anthony W.
Tang, Hsin-Yao
Speicher, David W.
Pestell, Richard G. https://orcid.org/0000-0003-3244-8777
-
Funding
Funding for this research was provided by:
Cytodyn Inc (Contract)
National Cancer Institute (R01CA132115)
U.S. Department of Defense (W81XWH1810605)
- License Information
-
More Information
Article History
Received: 30 April 2020
Accepted: 11 January 2021
First Online: 23 January 2021
Ethics approval and consent to participate
: Animal studies were approved by the Lankenau Institute for Medical Research Institutional Animal Care and Use Committee (IACUC).
: Not applicable
: R.G.P. holds ownership interests in, CytoDyn Inc. and LightSeed, Inc., receives income from the provision of testimony as an expert witness, serves on the advisory boards of Azure Health, and the MD Anderson Cancer Center Breast Cancer SPORE, and holds ownership interests (value unknown) for several patents and submitted patent applications. The other authors declare that they have no conflict of interest.
